Nachrichten zur Nektar Therapeutics Aktie

Nektar Therapeutics (NKTR) Presents At 39th Annual J.P. Morgan Healthcare Conference

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

NEKTAR THERAPEUTICS: 8-K Report

CURRENT REPORT...…

Nektar Therapeutics initiated at hold with $18 price target at Stifel

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

NEKTAR THERAPEUTICS: 8-K Report

CURRENT REPORT...…

Nektar Appoints Dr. Brian Kotzin as Interim Chief Medical Officer and Head of Development

SAN FRANCISCO , Jan. 5, 2021 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today that…

Implied Volatility Surging for Nektar Therapeutics (NKTR) Stock Options

Investors need to pay close attention to Nektar Therapeutics (NKTR) stock based on the movements in the options market lately....…

Nektar to sell Adynovate, Movantik Royalties for $150M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

NEKTAR THERAPEUTICS: 8-K Report

CURRENT REPORT...…

Nektar Therapeutics Announces Agreement with Healthcare Royalty to Sell ADYNOVATE® and MOVANTIK® Royalties for $150 Million

SAN FRANCISCO , Dec. 22, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that it…

Nektar (NKTR) Begins Dosing in NKTR-255 Study for Two Cancers

Nektar (NKTR) doses the first patient in a phase I/II study on NKTR-255 in combination with Erbitux for treating head…

Nektar Therapeutics Announces Presentation of Preclinical Data for NKTR-255, its Novel IL-15 Agonist, at the American Society of Hematology (ASH) 2020 Annual Meeting

SAN FRANCISCO , Dec. 7, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced…

Nektar Therapeutics: A Look At The SITC BEMPEG Data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics immuno-oncology candidates show positive action in early-stage studies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics Presents New Data from Its Immuno-Oncology Pipeline at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

SAN FRANCISCO , Nov. 11, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced…

Nektar (NKTR) Stock Up 3% on Q3 Earnings and Revenue Beat

Nektar (NKTR) reports encouraging third-quarter 2020 results. Enrollment in clinical studies back on track....…

Singapore-based sales productivity platform Nektar raises $2.15 million seed round

Singapore-based Nektar.ai, a productivity platform for sales teams, has raised $2.15 million in seed funding. Founded earlier this year, Nektar…

NEKTAR THERAPEUTICS: 10-Q Report

10-Q...…

Nektar Therapeutics (NKTR) Q3 2020 Earnings Call Transcript

NKTR earnings call for the period ending September 30, 2020....…

Nektar Therapeutics (NKTR) CEO Howard Robin on Q3 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of 23.75% and 39.34%, respectively, for the quarter ended September 2020. Do the…

Nektar Therapeutics Reports Third Quarter 2020 Financial Results

SAN FRANCISCO , Nov. 5, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today reported financial…

Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors for 2020 American College of Rheumatology (ACR) Congress

SAN FRANCISCO , Oct. 29, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today that…

Nektar to Announce Financial Results for the Third Quarter 2020 on Thursday, November 5, 2020, After Close of U.S.-Based Financial Markets

SAN FRANCISCO , Oct. 28, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce…

Nektar Therapeutics Announces Phase 1b Clinical Study to Evaluate Bempegaldesleukin for Treatment of Patients Diagnosed with Mild COVID-19

SAN FRANCISCO , Oct. 27, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that…

34 Kilo Honig pro Volk: Deutschlands Imker nur mit mittelmäßiger Ernte

WACHTBERG (dpa-AFX) - Deutschlands Imker haben dieses Jahr nur eine mittelmäßige Honigernte einholen können. Es sei zu trocken gewesen -…

Nektar (NKTR) Down 12% Since Last Earnings Report: Can It Rebound?

Nektar (NKTR) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Nektar Looks Undervalued, But The Biggest Value-Driving Events Are Still In 2021

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics (NKTR) CEO Howard Robin on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

NEKTAR THERAPEUTICS: 10-Q Report

10-Q...…

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of 34.78% and 113.84%, respectively, for the quarter ended June 2020. Do the…

Nektar Therapeutics Reports Second Quarter 2020 Financial Results

SAN FRANCISCO , Aug. 6, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended…

Nektar to Announce Financial Results for the Second Quarter 2020 on Thursday, August 6, 2020, After Close of U.S.-Based Financial Markets

SAN FRANCISCO , July 28, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its…

Nektar Therapeutics to host webcast on NKTR-358 data June 5

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors During 2020 Virtual European Congress of Rheumatology (EULAR 2020)

SAN FRANCISCO , May 29, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today…